Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1122/week)
    • Manufacturing(545/week)
    • Energy(433/week)
    • Technology(1116/week)
    • Other Manufacturing(347/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Hoth Therapeutics, Inc.

Sep 24, 2025
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities
Sep 04, 2025
Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development
Jul 29, 2025
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe
Jun 24, 2025
Hoth Therapeutics HT-001 Interim Results First-in-Class Topical Therapy Preserves Cancer Treatment While Resolving Dermatologic Side Effects
Jun 23, 2025
Hoth Therapeutics to host KOL Event Spotlighting HT-001, Novel Therapy
Jun 18, 2025
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward Growth
Jun 16, 2025
Hoth Therapeutics to Attend 2025 BIO International Convention
Jun 12, 2025
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases
Jun 11, 2025
Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities
Jun 05, 2025
Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities
Mar 31, 2025
Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage
Mar 26, 2025
Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation
Mar 18, 2025
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment
Mar 05, 2025
Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting
Mar 04, 2025
Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease
Feb 10, 2025
Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
Jan 08, 2025
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries
Oct 29, 2024
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study
Sep 05, 2024
Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial
Sep 05, 2024
Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001
  •  
  • Page 1
  • ››

Latest News

Sep 26, 2025

Kimball Electronics, Inc. Announces Annual Meeting Of Share Owners

Sep 26, 2025

LibertyStream Announces Corporate Updates

Sep 26, 2025

U. S. Steel Welcomes ITC Action to Protect American Steel Industry

Sep 26, 2025

Clean Harbors Prices Offering of Senior Notes Due 2033

Sep 26, 2025

World’s Largest Nonprofit Sportfishing Tournament for Veterans, War Heroes on Water, Wraps Eighth Annual...

Sep 26, 2025

Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education

Sep 26, 2025

WindShape Opens First U.S. Facility in Tulsa

Sep 26, 2025

Freudenberg Medical Opens Second Production Facility in Costa Rica

View all News

Agenda

27
January
United States of AmericaThe Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA
Future Indirect Fires, January 27-28, 2026, The Westin Arlington, Arlington, VA Supporting Next-Generation Capability...
03
December
United Kingdom Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems, 3 - 4 December 2025, Copthorne Tara Hotel, London, UK
Uncrewed & Autonomous Systems | 3 - 4 December 2025| Copthorne Tara Hotel, London, UK   Uncrewed & Autonomous...
28
October
Copthorne Tara Hotel, London, UK
Maritime ISR, 28-29 October 2025, Copthorne Tara Hotel, London, UK
Maritime ISR | 28-29 October 2025 | Copthorne Tara Hotel, London, UK   This year’s conference brings together senior...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia